Making Neuromodulation Financially Viable: Business Models, Workforce Planning and Sustainable Program Design
Part of Plenary III: From Vision to Value: Leading the Future of Neuromodulation
Details
- Date
- Saturday, January 23, 2027
- Time
- 8:50 AM – 9:05 AM
- Session type
- Plenary
- Schedule
- See this day
About
As neuromodulation continues to expand across indications and care settings, ensuring its long-term impact requires more than scientific innovation alone. This plenary session explores the strategic, operational, and policy frameworks necessary to advance the field from promising therapies to sustainable standards of care. Faculty will examine the development of the first NANS clinical practice guidelines, discuss practical approaches to building financially viable neuromodulation programs, and explore how value-based care models can strengthen partnerships with payers by drawing lessons from other medical specialties. The session culminates with the NANS Presidential Address, highlighting our vision for the future of neuromodulation, followed by the Lifetime Achievement Address honoring an individual whose contributions have profoundly shaped the field.
Presenters
-
Dr. Joshua M. Rosenow, MD, FAANS, FCNS, FACS is Director of Functional Neurosurgery and Professor of Neurosurgery, Neurology and PM&R at Northwestern University.
He graduated from Yale University School of Medicine, completed training at NYMC and then fellowship in stereotactic, functional, restorative neurosurgery and epilepsy surgery at Cleveland Clinic. He is one of the founding members of the Functional Neurosurgery Working Group of the Parkinson’s Study Group.
Research interests include stereotactic surgery, neurostimulation for enhancement of neurologic recovery, imaging biomarkers in pain, socioeconomic aspects of neurosurgery/neuromodulation, opioid policy, exploration of brain function using implanted electrodes, brain-machine interface and novel neurologic devices
He has served as President of the Illinois State Neurosurgical Society, Chair of AANS/CNS Joint Section on Pain, and Chair of CSNS. He has served on the Executive Council of the ASSFN and the Board of Directors of NANS.
Dr. Rosenow is one of 6 members of the AANS/CNS Washington Committee, Chair of AANS/CNS Drugs and Devices Committee, delegate to the AMA from AANS and alternate CPT advisor for Neurosurgery. He is Co-Chair of NANS Advocacy and Policy Committee. He has been honored with the Randall Smith Meritorious Service Award from CSNS and Presidential Award from NANS.
-
David A. Provenzano, MD
President of Pain Diagnostics and Interventional Care
Pain Diagnostics and Interventional Care · Sewickley, Pennsylvania
Dr. David Provenzano is the president of Pain Diagnostics and Interventional Care. He is a member of the executive committee of the Medical Staff at Western PA Surgery Center and serves on the Heritage Valley Healthcare Network CIN/ACO Quality Assurance Committees. Dr. Provenzano has received multiple awards for his academic and clinical accomplishment including the 2024 North American Neuromodulation Society Presidential Award and the European Society Regional Anesthesia and Pain Therapy (ESRA-Spain) Distinguished Service Award.
Dr. Provenzano received his undergraduate degree from Colgate University. He went on to earn his medical degree from the University of Rochester School of Medicine and Dentistry, followed by a surgical internship at Thomas Jefferson University Hospital and a residency in anesthesiology at The Western Pennsylvania Hospital. He completed a pain management fellowship at the Dartmouth Hitchcock Medical Center.
Dr. Provenzano has authored over 100 scientific articles and led many research studies focused on neuromodulation, radiofrequency lesioning, ultrasound, and healthcare safety. He is past president of ASRA Pain Medicine, serves as its AMA House of Delegates Representative, and co-chairs the NANS Advocacy and Policy Committee.